Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Ganglioneuroma staging

Introduction

Overview

Overview

According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on clinical, radiologic, and surgical features.[1]

Staging

Staging

According to the International Neuroblastoma Staging System (INSS), there are six stages of ganglioneuroma based on clinical, radiologic, and surgical features.[1]

Stage 1

  • Localized tumor confined to the area of origin
  • Complete gross excision, with or without microscopically residual disease
  • Identifiable ipsilateral and contralateral lymph node negative microscopically

Stage 2A

  • Unilateral tumor with incomplete gross excision
  • Identifiable ipsilateral nonadherent lymph node negative microscopically

Stage 2B

  • Unilateral tumor with complete or incomplete gross excision
  • Positive ipsilateral nonadherent lymph nodes
  • Identifiable contralateral lymph node negtive microscopically

Stage 3

  • Tumor infiltrating across the midline (vertebral column) with or without regional lymph node involvement
OR
  • Unilateral tumor with contralateral regional lymph node involvement
OR
  • Midline tumor with bilateral regional lymph node involvement or extension by infiltration

Stage 4

  • Dissemination of tumor to distant lymph nodes, bone, bone marrow, liver or other organs (except as defined in stage 4S)

Stage 4S

  • Localized primary tumor as defined for stage 1 or 2 with dissemination limited to liver, skin, and/or bone marrow (<10% tumor) in infants younger than 1 yr
References

References

  1. ↑ 1.0 1.1 Adam, O; Boia, ES (2007). “ganglioneuroma” (PDF). jurnalul pediatrului. 10 (39–40). Retrieved 10 September 2015.


Template:WikiDoc Sources

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]